France· FR:60694593
VABOREM 1 g/1 g, poudre pour solution à diluer pour perfusion
A medicinal product containing vaborbactam + méropénem trihydraté, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VABORBACTAM + MÉROPÉNEM TRIHYDRATÉ
- Manufacturer
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301854696 flacons en verre de 50 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vaborbactam + méropénem trihydraté in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVaborem 1g/1g, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA. Menarini GmbH
- CzechiaVABOREMMenarini International Operations Luxembourg S.A., Luxembourg
- SpainVABOREM 1 G/1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMenarini International Operations Luxembourg S.A.
- FinlandVaboremMenarini International Operations Luxembourg S.A.
- United KingdomVaborem 1g/1g powder for concentrate for solution for infusion vialsA. Menarini Farmaceutica Internazionale SRL
- IrelandVaborem 1 g/1 g powder for concentrate for solution for infusionMenarini International Operations Luxembourg S.A.
- IcelandVaboremMenarini International Operations Luxembourg S.A.
- NetherlandsVaborem 1 g/1 g, poeder voor concentraat voor oplossing voor infusieMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vaborem
- Liechtenstein · Vaborem
- Norway · Vaborem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/05c66eaf-83fe-44e8-abc6-5a30154f86e9 GET /v1/drugs/05c66eaf-83fe-44e8-abc6-5a30154f86e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60694593",
"date_amm": "2018-11-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/18/1334",
"substance": "VABORBACTAM + MÉROPÉNEM TRIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vaborbactam + méropénem trihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.